Protriptyline Hydrochloride
Pricing Report NDC 50383-959-10

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Protriptyline Hydrochloride (NDC 50383-959-10) is $1.59953 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Feb 22, 2017.

As a provided by Akorn, this medication is distributed in a 100 TABLET, FILM COATED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.59953
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Feb 22, 2017
Billable Units
100 EA
Estimated Package Price
$159.95
Data Status
As of Mar 14, 2018
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
50383-959-10
Description
100 TABLET, FILM COATED in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Dec 2013, the NADAC wholesale price for (NDC ) has moved within a range of $1.06642 to $1.78050 per EA. Over this 3 years and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.0664 - $1.7805
Market Volatility
66.96% Variance
Latest Trend
4.74%
Date Unit Price Unit Source Method Rate
Feb 22, 2017 $1.59953 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 22, 2017 $1.59953 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Jul 20, 2016 $1.67920 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 20, 2016 $1.67920 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Jun 22, 2016 $1.64554 EAC/I - Chain or Independent PharmacyCode 1G - Generic
May 18, 2016 $1.71098 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 20, 2016 $1.49689 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 22, 2015 $1.30342 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 22, 2015 $1.30342 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Feb 18, 2015 $1.57637 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 18, 2015 $1.57637 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Jan 21, 2015 $1.45828 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 17, 2014 $1.64182 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 19, 2014 $1.29746 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Aug 20, 2014 $1.78050 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Aug 20, 2014 $1.78050 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Jul 23, 2014 $1.62388 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 19, 2014 $1.06642 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 19, 2014 $1.06642 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2014 $1.06642 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Jan 22, 2014 $1.10180 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2013 $1.09908 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026